News
-
-
PRESS RELEASE
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
Sanofi announces acquisition of Dynavax Technologies Corporation, expanding adult vaccine portfolio with hepatitis B and shingles candidates. Merger valued at $2.2 billion -
-
PRESS RELEASE
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi provides update on tolebrutinib regulatory submission for non-relapsing secondary progressive multiple sclerosis, with FDA issuing a complete response letter and further guidance expected in Q1 2026 -
-
-
-
-
-
PRESS RELEASE
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Sanofi and Regeneron's Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma, showing significant reduction in exacerbations and improved lung function in phase 3 studies
